Xponance’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.7M | Buy |
23,642
+424
| +2% | +$227K | 0.11% | 157 |
|
|
2025
Q1 | $9.75M | Buy |
23,218
+240
| +1% | +$101K | 0.09% | 172 |
|
|
2024
Q4 | $9.5M | Buy |
22,978
+4,139
| +22% | +$1.71M | 0.09% | 183 |
|
|
2024
Q3 | $9.52M | Sell |
18,839
-232
| -1% | -$117K | 0.09% | 173 |
|
|
2024
Q2 | $9.29M | Buy |
19,071
+122
| +0.6% | +$59.4K | 0.1% | 157 |
|
|
2024
Q1 | $10.2M | Buy |
18,949
+47
| +0.2% | +$25.4K | 0.11% | 160 |
|
|
2023
Q4 | $10.5M | Sell |
18,902
-252
| -1% | -$140K | 0.13% | 136 |
|
|
2023
Q3 | $8.38M | Buy |
19,154
+264
| +1% | +$115K | 0.11% | 153 |
|
|
2023
Q2 | $9.49M | Buy |
18,890
+430
| +2% | +$216K | 0.13% | 130 |
|
|
2023
Q1 | $9.23M | Buy |
18,460
+238
| +1% | +$119K | 0.13% | 134 |
|
|
2022
Q4 | $7.43M | Buy |
18,222
+1,409
| +8% | +$575K | 0.12% | 163 |
|
|
2022
Q3 | $5.48M | Buy |
16,813
+1,357
| +9% | +$442K | 0.11% | 174 |
|
|
2022
Q2 | $5.42M | Sell |
15,456
-1,167
| -7% | -$409K | 0.11% | 160 |
|
|
2022
Q1 | $9.09M | Buy |
16,623
+145
| +0.9% | +$79.3K | 0.15% | 120 |
|
|
2021
Q4 | $10.9M | Buy |
16,478
+1,171
| +8% | +$771K | 0.17% | 98 |
|
|
2021
Q3 | $9.52M | Sell |
15,307
-4,586
| -23% | -$2.85M | 0.18% | 97 |
|
|
2021
Q2 | $12.6M | Sell |
19,893
-1,342
| -6% | -$848K | 0.23% | 77 |
|
|
2021
Q1 | $10.4M | Buy |
21,235
+8,856
| +72% | +$4.33M | 0.22% | 84 |
|
|
2020
Q4 | $6.19M | Buy |
12,379
+148
| +1% | +$74K | 0.13% | 134 |
|
|
2020
Q3 | $4.81M | Buy |
12,231
+97
| +0.8% | +$38.1K | 0.12% | 155 |
|
|
2020
Q2 | $4.01M | Buy |
+12,134
| New | +$4.01M | 0.1% | 172 |
|